Berkeley-Tsinghua Transnational IP Litigation Program Launches Soon

Berkeley Law has just opened up registration for our third annual Berkeley-Tsinghua program on Transnational IP Litigation with Tsinghua Law School which will take place January 21, 22, 28 and 29. The agenda is here.  Registration is here.

The program will focus on IP litigation during a time of trade tension.  We will look at such issues as: the role of private IP litigation in the trade war and the Phase 1 Trade Agreement; the growth of SEP-related litigation  (including anti-suit injunctions); China’s efforts to become a center for international IP litigation and best practices in international IP litigation; emerging conflict of law issues; trade secret litigation in China and the US, (including Section 337); the changing landscape for IP protection for pharmaceutical products in China; and anti-counterfeiting liigation in the US against Chinese banks as payment processors. We have an international faculty of judges, lawyers, officials, practitioners, and academics.   From the federal bench, the program will include Judges Ray Chen, Kent Jordan, Randall Rader (ret.), Jeremy Fogel (ret.) and Andrew Guilford (ret.).

This year the program is free to academics, students, government officials and the media.  CLE is available for paid registrants.

Please consider joining us!

(Logo prepared by Tsinghua Law School)

Upcoming China Pharma IP Program

The Berkeley Center for Law and Technology will be launching a five-part webinar series on “Innovation, Regulation in the Life Sciences” on November 17 from 4:30-6:00 PM.   The launch program is devoted to “China’s Emerging Regime for IP In the Life Sciences”. 

Joining me for the program will be He Jing from the Gen Law firm, Dr. Karen Guo from Novo Nordisk, Xuejiao Hu from Beigene, Prof. Guobin Cui from Tsinghua Law School and Dr. Can Cui from Morrison & Foerster.  CLE credit will be provided. 

Students and media are free of charge, BCLT sponsors are half-price. We expect to cover the full range of issues in this first session: patent linkage, regulatory data protection, patent prosecution, the recent SAMR rule and SPC judicial interpretation, etc.  A package of English language reading materials is also available for attendees. The programs costs $75.00 for the session and $300.00 for the series. 

Other sessions in the series include: FDA Innovation, Food Innovation, Drug Pricing and Sharing Data for Research and Development.

Upcoming Town Hall at Duke University on Bilateral Relations and Innovation

I will  be speaking November 10, 2020 at an upcoming National Committee on US-China Relations Town Hall, hosted by Duke University and focusing on science and technology relations. Prof. Denis Simon of Duke University is the host, and we will be joined by Prof. Richard P. Suttmeier (U of Oregon),  and Paul S. Triolo (Eurasia Group). 

The program should provide some useful insights on China’s changing environment for innovation,  including the impact on ICT, standardization, talent migration and of course, IP.  

The program begins at 6:50 PM EST and is free of charge.